LCLuca Campora

Luca Campora

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Luca Campora has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Cannabinoid receptor type 1 and 2 expression in the skin of healthy dogs and dogs with atopic dermatitis

    by Luca Campora, Vincenzo Miragliotta, Emanuele Ricci, Luigia Cristino, Vincenzo Di Marzo, Francesco Albanese, Maria Federica della Valle, Francesca Abramo

    Objective—To determine the distribution of cannabinoid receptor type 1 (CB1) and cannabinoid receptor type 2 (CB2) in skin (including hair follicles and sweat and sebaceous glands) of clinically normal dogs and dogs with atopic dermatitis (AD) and to compare results with those for positive control samples for CB1 (hippocampus) and CB2 (lymph nodes). Sample—Skin samples from 5 healthy dogs and 5 dogs with AD and popliteal lymph node and hippocampus samples from 5 cadavers of dogs. Procedures—CB1 and CB2 were immunohistochemically localized in formalin-fixed, paraffin-embedded sections of tissue samples. Results—In skin samples of healthy dogs, CB1 and CB2 immunoreactivity was detected in various types of cells in the epidermis and in cells in the dermis, including perivascular cells with mast cell morphology, fibroblasts, and endothelial cells. In skin samples of dogs with AD, CB1 and CB2 immunoreactivity was stronger than it was in skin samples of healthy dogs. In positive control tissue samples, CB1 immunoreactivity was detected in all areas of the hippocampus, and CB2 immunoreactivity was detected in B-cell zones of lymphoid follicles. Conclusions and Clinical Relevance—The endocannabinoid system and cannabimimetic compounds protect against effects of allergic inflammatory disorders in various species of mammals. Results of the present study contributed to knowledge of the endocannabinoid system and indicated this system may be a target for treatment of immune-mediated and inflammatory disorders such as allergic skin diseases in dogs.


  • Open Access

    Mycobacterium aviumsubspecieshominissuisdisseminated infection in a Basset Hound dog

    by Luca Campora, Michele Corazza, Cristina Zullino, Valentina V. Ebani, Francesca Abramo

    In the current report, a case in Italy of disseminated Mycobacterium avium subsp. hominissuis infection in a dog from an American lineage of Basset Hounds is described. A 2-year-old intact female Basset Hound presented with persistent lymphadenopathy, lameness, and a history characterized by coccidiosis, bacterial gastroenteritis, and alopecia. Lymphadenitis, with macrophages containing a few intracytoplasmic, negative staining, Ziehl–Neelsen-positive bacilli, was detected by a popliteal fine-needle aspirate leading to the diagnosis of mycobacteriosis. Ultrasound and X-ray examinations revealed visceral and mediastinal lymphadenopathy. Because of the extent of the disease, the dog was humanely euthanized. Significant gross abnormalities, such as enlargement of the cranial mediastinal lymph nodes with encapsulated areas of caseous necrosis and generalized lymphadenopathy, were observed at necropsy. Granulomatous lesions were histopathologically detected in the liver and spleen. Ziehl–Neelsen-positive bacilli were observed in all examined lymph node, liver, spleen, lung, and bone marrow smears. Lymph nodes and liver were collected in order to pursue speciation by bacterial culture and molecular biology; multiplex polymerase chain reaction results classified the pathogen as M. avium subsp. hominissuis. Although an immune system deficiency was not investigated, anamnesis suggests that the dog was immunocompromised. Furthermore, the dog came from an American stock of Basset Hound, and for some of this breed, a predisposition to this infection has been hypothesized.